Nuclear-targeted inhibition of NF-κB on MMP-9 production by N-2-(4-bromophenyl) ethyl caffeamide in human monocytic cells

Chemico-Biological Interactions

Volumn 184, Issue 3, 2010, Pages 403-412

  Chou, Yung Chen ^a   Sheu, Joen Rong ^a   Chung, Chi Li ^b   Chen, Chung Yung ^c   Lin, Fan Li ^a   Hsu, Ming Jen ^a   Kuo, Yueh Hsiung ^d,e,f   Hsiao, George ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e AGRICULTURAL BIOTECHNOLOGY RESEARCH CENTER   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

MMP 9; Monocyte; NF B; TNF

Indexed keywords

ANTINEOPLASTIC AGENT; EK 1; EK 2; EK 3; EK 4; EK 5; EK 6; GELATINASE B; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N 2 (3 FLUROPHENYL) ETHYL CAFFEAMIDE; N 2 (3,4 DIMETHOXYPHENYL) ETHYL 3,4 METHYLENECAFFEAMIDE; N 2 (4 BROMOPHENYL) ETHYL CAFFEAMIDE; N 2 PHENYLETHYL 3,4 METHYLENECAFFEAMIDE; N HYDROXYCINNAMOYLPHENALKYLAMIDE DERIVATIVE; N PHENYL 3,4 METHYLENECAFFEAMIDE; N TOLYL 3,4 METHYLENECAFFEAMIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE MONOCYTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL VIABILITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; DOWN REGULATION; DRUG EFFICACY; DRUG STRUCTURE; ENZYME INHIBITION; GENE TRANSLOCATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REPORTER GENE; SIGNAL TRANSDUCTION;

CAFFEIC ACIDS; CELL LINE; CELL NUCLEUS; HUMANS; MATRIX METALLOPROTEINASE 9; MONOCYTES; NF-KAPPA B; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77949912138     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.01.010     Document Type: Article

References (63)

1. Bode W., Maskos K. Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases. Biol. Chem. 2003, 384:863-872.
2. Brew K., Dinakarpandian D., Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim. Biophys. Acta 2000, 1477:267-283.
3. Bode W., Fernandez-Catalan C., Grams F., Gomis-Ruth F.X., Nagase H., Tschesche H., Maskos K. Insights into MMP-TIMP interactions. Ann. N. Y. Acad. Sci. 1999, 878:73-91.
4. Steffensen B., Hakkinen L., Larjava H. Proteolytic events of wound-healing-coordinated interactions among matrix metalloproteinases (MMPs), integrins, and extracellular matrix molecules. Crit. Rev. Oral Biol. Med. 2001, 12:373-398.
5. Konttinen Y.T., Ainola M., Valleala H., Ma J., Ida H., Mandelin J., Kinne R.W., Santavirta S., Sorsa T., Lopez-Otin C., Takagi M. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann. Rheum. Dis. 1999, 58:691-697.
6. Tetlow L.C., Adlam D.J., Woolley D.E. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum. 2001, 44:585-594.
7. Sternlicht M.D., Werb Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 2001, 17:463-516.
8. Moon S.K., Cha B.Y., Kim C.H. ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: Involvement of the ras dependent pathway. J. Cell Physiol. 2004, 198:417-427.
9. Bond M., Fabunmi R.P., Baker A.H., Newby A.C. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Lett. 1998, 435:29-34.
10. Chen L.F., Greene W.C. Shaping the nuclear action of NF-kappaB. Nat. Rev. Mol. Cell Biol. 2004, 5:392-401.
11. Ghosh S., Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002, 109(Suppl.):S81-S96.
12. Hayden M.S., Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008, 132:344-362.
13. Dichamp I., Bourgeois A., Dirand C., Herbein G., Wendling D. Increased nuclear factor-kappaB activation in peripheral blood monocytes of patients with rheumatoid arthritis is mediated primarily by tumor necrosis factor-alpha. J. Rheumatol. 2007, 34:1976-1983.
14. Chan G., Bivins-Smith E.R., Smith M.S., Yurochko A.D. Transcriptome analysis of NF-kappaB- and phosphatidylinositol 3-kinase-regulated genes in human cytomegalovirus-infected monocytes. J. Virol. 2008, 82:1040-1046.
15. Shalit I., Halperin D., Haite D., Levitov A., Romano J., Osherov N., Fabian I. Anti-inflammatory effects of moxifloxacin on IL-8, IL-1beta and TNF-alpha secretion and NFkappaB and MAP-kinase activation in human monocytes stimulated with Aspergillus fumigatus. J. Antimicrob. Chemother. 2006, 57:230-235.
16. Hsu H., Xiong J., Goeddel D.V. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 1995, 81:495-504.
17. Devin A., Cook A., Lin Y., Rodriguez Y., Kelliher M., Liu Z. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity 2000, 12:419-429.
18. Zandi E., Rothwarf D.M., Delhase M., Hayakawa M., Karin M. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 1997, 91:243-252.
19. Park J.B., Schoene N. N-Caffeoyltyramine arrests growth of U937 and Jurkat cells by inhibiting protein tyrosine phosphorylation and inducing caspase-3. Cancer Lett. 2003, 202:161-171.
20. Okombi S., Rival D., Bonnet S., Mariotte A.M., Perrier E., Boumendjel A. Analogues of N-hydroxycinnamoylphenalkylamides as inhibitors of human melanocyte-tyrosinase. Bioorg. Med. Chem. Lett. 2006, 16:2252-2255.
21. Jin U.H., Chung T.W., Kang S.K., Suh S.J., Kim J.K., Chung K.H., Gu Y.H., Suzuki I., Kim C.H. Caffeic acid phenyl ester in propolis is a strong inhibitor of matrix metalloproteinase-9 and invasion inhibitor: isolation and identification. Clin. Chim. Acta 2005, 362:57-64.
22. Lee K.W., Kang N.J., Kim J.H., Lee K.M., Lee D.E., Hur H.J., Lee H.J. Caffeic acid phenethyl ester inhibits invasion and expression of matrix metalloproteinase in SK-Hep1 human hepatocellular carcinoma cells by targeting nuclear factor kappa B. Genes Nutr. 2008, 2:319-322.
23. Son S., Lewis B.A. Free radical scavenging and antioxidative activity of caffeic acid amide and ester analogues: structure-activity relationship. J. Agric. Food Chem. 2002, 50:468-472.
24. Hsiao G., Shen M.Y., Chang W.C., Cheng Y.W., Pan S.L., Kuo Y.H., Chen T.F., Sheu J.R. A novel antioxidant, octyl caffeate, suppression of LPS/IFN-gamma-induced inducible nitric oxide synthase gene expression in rat aortic smooth muscle cells. Biochem. Pharmacol. 2003, 65:1383-1392.
25. Chung C.L., Sheu J.R., Liu H.E., Chang S.C., Chou Y.C., Chen W.L., Chou D.S., Hsiao G. Dynasore, a dynamin inhibitor, induces PAI-1 expression in MeT-5A human pleural mesothelial cells. Am. J. Respir. Cell Mol. Biol 2009, 40:692-700.
26. Hsiao G., Huang H.Y., Fong T.H., Shen M.Y., Lin C.H., Teng C.M., Sheu J.R. Inhibitory mechanisms of YC-1 and PMC in the induction of iNOS expression by lipoteichoic acid in RAW 264.7 macrophages. Biochem. Pharmacol. 2004, 67:1411-1419.
27. Sitrin R.G., Pan P.M., Srikanth S., Todd R.F. Fibrinogen activates NF-kappa B transcription factors in mononuclear phagocytes. J. Immunol. 1998, 161:1462-1470.
28. Fukuyama R., Ng K.P., Cicek M., Kelleher C., Niculaita R., Casey G., Sizemore N. Role of IKK and oscillatory NFkappaB kinetics in MMP-9 gene expression and chemoresistance to 5-fluorouracil in RKO colorectal cancer cells. Mol. Carcinog. 2007, 46:402-413.
29. Saadane A., Masters S., DiDonato J., Li J., Berger M. Parthenolide inhibits IkappaB kinase, NF-kappaB activation, and inflammatory response in cystic fibrosis cells and mice. Am. J. Respir. Cell Mol. Biol. 2007, 36:728-736.
30. Nicholas C., Batra S., Vargo M.A., Voss O.H., Gavrilin M.A., Wewers M.D., Guttridge D.C., Grotewold E., Doseff A.I. Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-kappaB through the suppression of p65 phosphorylation. J. Immunol. 2007, 179:7121-7127.
31. Doedens J.R., Black R.A. Stimulation-induced down-regulation of tumor necrosis factor-alpha converting enzyme. J. Biol. Chem. 2000, 275:14598-14607.
32. Murphy G., Nagase H. Progress in matrix metalloproteinase research. Mol. Aspects Med. 2008, 29:290-308.
33. Hu J., Van den Steen P.E., Sang Q.X., Opdenakker G. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nat. Rev. Drug Discov. 2007, 6:480-498.
34. Ihnatko R., Kubes M. TNF signaling: early events and phosphorylation. Gen. Physiol. Biophys. 2007, 26:159-167.
35. Ashkenazi A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat. Rev. Cancer 2002, 2:420-430.
36. Kasama T., Miwa Y., Isozaki T., Odai T., Adachi M., Kunkel S.L. Neutrophil-derived cytokines: potential therapeutic targets in inflammation. Curr. Drug Targets Inflamm. Allergy 2005, 4:273-279.
37. Locksley R.M., Killeen N., Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001, 104:487-501.
38. Aggarwal B.B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 2003, 3:745-756.
39. Xue M., Fan Y., Liu S., Zygun D.A., Demchuk A., Yong V.W. Contributions of multiple proteases to neurotoxicity in a mouse model of intracerebral haemorrhage. Brain 2009, 132:26-36.
40. Heidinger M., Kolb H., Krell H.W., Jochum M., Ries C. Modulation of autocrine TNF-alpha-stimulated matrix metalloproteinase 9 (MMP-9) expression by mitogen-activated protein kinases in THP-1 monocytic cells. Biol. Chem. 2006, 387:69-78.
41. Henderson R.B., Hobbs J.A., Mathies M., Hogg N. Rapid recruitment of inflammatory monocytes is independent of neutrophil migration. Blood 2003, 102:328-335.
42. Normann S.J., Noga S.J. Population kinetic study of guinea pig monocytes and their subsets during acute inflammation. Cell Immunol. 1986, 101:534-547.
43. Opdenakker G., Masure S., Grillet B., Van Damme J. Cytokine-mediated regulation of human leukocyte gelatinases and role in arthritis. Lymphokine Cytokine Res. 1991, 10:317-324.
44. Opdenakker G., Masure S., Proost P., Billiau A. J. van Damme, Natural human monocyte gelatinase and its inhibitor. FEBS Lett. 1991, 284:73-78.
45. Welgus H.G., Campbell E.J., Cury J.D., Eisen A.Z., Senior R.M., Wilhelm S.M., Goldberg G.I. Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. J. Clin. Invest. 1990, 86:1496-1502.
46. Chong Y.H., Sung J.H., Shin S.A., Chung J.H., Suh Y.H. Effects of the beta-amyloid and carboxyl-terminal fragment of Alzheimer's amyloid precursor protein on the production of the tumor necrosis factor-alpha and matrix metalloproteinase-9 by human monocytic THP-1. J. Biol. Chem. 2001, 276:23511-23517.
47. Borden P., Heller R.A. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit. Rev. Eukaryot. Gene Expr. 1997, 7:159-178.
48. Ghosh S., Hayden M.S. New regulators of NF-kappaB in inflammation. Nat. Rev. Immunol. 2008, 8:837-848.
49. Giannopoulou M., Dai C., Tan X., Wen X., Michalopoulos G.K., Liu Y. Hepatocyte growth factor exerts its anti-inflammatory action by disrupting nuclear factor-kappaB signaling. Am. J. Pathol. 2008, 173:30-41.
50. Woo J.H., Park J.W., Lee S.H., Kim Y.H., Lee I.K., Gabrielson E., Lee H.J., Kho Y.H., Kwon T.K. Dykellic acid inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting nuclear factor kappa B transcriptional activity. Cancer Res. 2003, 63:3430-3434.
51. Duran A., Diaz-Meco M.T., Moscat J. Essential role of RelA Ser311 phosphorylation by zetaPKC in NF-kappaB transcriptional activation. EMBO J. 2003, 22:3910-3918.
52. Zhong H., Voll R.E., Ghosh S. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell 1998, 1:661-671.
53. Perkins N.D. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat. Rev. Mol. Cell Biol. 2007, 8:49-62.
54. Chen L.F., Williams S.A., Mu Y., Nakano H., Duerr J.M., Buckbinder L., Greene W.C. NF-kappaB RelA phosphorylation regulates RelA acetylation. Mol. Cell Biol. 2005, 25:7966-7975.
55. Hoberg J.E., Popko A.E., Ramsey C.S., Mayo M.W. IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300. Mol. Cell Biol. 2006, 26:457-471.
56. Sasaki C.Y., Barberi T.J., Ghosh P., Longo D.L. Phosphorylation of RelA/p65 on serine 536 defines an I{kappa}B{alpha}-independent NF-{kappa}B pathway. J. Biol. Chem. 2005, 280:34538-34547.
57. Douillette A., Bibeau-Poirier A., Gravel S.P., Clement J.F., Chenard V., Moreau P., Servant M.J. The proinflammatory actions of angiotensin II are dependent on p65 phosphorylation by the IkappaB kinase complex. J. Biol. Chem. 2006, 281:13275-13284.
58. Quivy V., Van Lint C. Regulation at multiple levels of NF-kappaB-mediated transactivation by protein acetylation. Biochem. Pharmacol. 2004, 68:1221-1229.
59. Ogryzko V.V., Schiltz R.L., Russanova V., Howard B.H., Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 1996, 87:953-959.
60. Ma Z., Shah R.C., Chang M.J., Benveniste E.N. Coordination of cell signaling, chromatin remodeling, histone modifications, and regulator recruitment in human matrix metalloproteinase 9 gene transcription. Mol. Cell Biol. 2004, 24:5496-5509.
61. Basu S., Pathak S., Pathak S.K., Bhattacharyya A., Banerjee A., Kundu M., Basu J. Mycobacterium avium-induced matrix metalloproteinase-9 expression occurs in a cyclooxygenase-2-dependent manner and involves phosphorylation- and acetylation-dependent chromatin modification. Cell Microbiol. 2007, 9:2804-2816.
62. Lee C.W., Lin C.C., Lin W.N., Liang K.C., Luo S.F., Wu C.B., Wang S.W., Yang C.M. TNF-alpha induces MMP-9 expression via activation of Src/EGFR, PDGFR/PI3K/Akt cascade and promotion of NF-kappaB/p300 binding in human tracheal smooth muscle cells. Am. J. Physiol. Lung Cell Mol. Physiol. 2007, 292:L799-812.
63. Lu Y., Wahl L.M. Production of matrix metalloproteinase-9 by activated human monocytes involves a phosphatidylinositol-3 kinase/Akt/IKKalpha/NF-kappaB pathway. J. Leukoc. Biol. 2005, 78:259-265.